ANZ Journal of Surgery | 2021
Isolated cerebral fat embolism syndrome: an extremely rare complication in orthopaedic patients
Abstract
1. Pamporaki C, Hamplova B, Peitzsch M et al. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 2017; 102: 1122–32. 2. Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from epidemiology to clinical findings. Sisli Etfal Hastan Tip Bul. 2020; 54: 159–68. 3. Giavarini A, Chedid A, Bobrie G, Plouin P-F, Hagege A, Amar L. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 2013; 99: 1438–44. 4. Chen H, Sippel RS, O’Dorisio MS et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 2010; 39: 775–83. 5. Burnichon N, Brière JJ, Libé R et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 2010; 19: 3011–20. 6. Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM. The genetic basis of pheochromocytoma and paraganglioma: implications for management. Urology 2014; 83: 1225–32. 7. Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs, 4th edn, Vol. 10. Lyon, France: International Agency for Research on Cancer, 2017. 8. Kimura N, Takekoshi K, Naruse M. Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine. J. Clin. Med. 2018; 7: 242.